Cargando…
Stem cell-based therapy for neonatal lung disease—it’s in the juice
Bronchopulmonary dysplasia (BPD), the chronic lung disease of prematurity, is the most common complication in extreme premature infants (born before 28 weeks gestation). Despite advances in perinatal care, modern clinical management remains devoid of therapies specifically promoting lung repair and...
Autores principales: | Fung, Moses E., Thébaud, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940470/ https://www.ncbi.nlm.nih.gov/pubmed/24126817 http://dx.doi.org/10.1038/pr.2013.176 |
Ejemplares similares
-
Stem Cell Therapy for Preventing Neonatal Diseases in the 21(st) Century: Current Understanding and Challenges
por: Nitkin, Christopher R., et al.
Publicado: (2019) -
Mesenchymal Stromal Cell-Derived Extracellular Vesicles for Neonatal Lung Disease: Tiny Particles, Major Promise, Rigorous Requirements for Clinical Translation
por: Lesage, Flore, et al.
Publicado: (2022) -
Stem Cells and Their Mediators – Next Generation Therapy for Bronchopulmonary Dysplasia
por: Möbius, Marius A., et al.
Publicado: (2015) -
The Therapeutic Potential of Stem Cells for Bronchopulmonary Dysplasia: “It’s About Time” or “Not so Fast” ?
por: Ee, Mong Tieng, et al.
Publicado: (2018) -
Using Cell-Based Strategies to Break the Link between Bronchopulmonary Dysplasia and the Development of Chronic Lung Disease in Later Life
por: O'Reilly, Megan, et al.
Publicado: (2013)